RareResearch.AI
← Back to atlas

A59V

AlphaMissense: likely benign (0.07)Uncertain significanceCytoplasmic · predicted
Alanine → Valine at position 59 · N-terminal cytoplasmic (intrinsically disordered) · WFS1 (Wolframin)

Interactive 3D Structure

Interactive structure
rotate · zoom · variant + 5 Å neighbors
Fullscreen ↗

Computational Predictions

AlphaMissense
0.074
likely benign
AlphaFold pLDDT
28
model confidence
DynaMut2 ΔΔG
pending
not yet computed
ClinVar
Uncertain significance
Uncertain significance

AlphaMissense + AlphaFold card. This variant is mapped from AlphaMissense pathogenicity and AlphaFold confidence. The DynaMut2 ΔΔG stability prediction and the wild-type/mutant structural comparison (dual-pane + bond network) are computed per-variant and backfill here — they require a DynaMut2 submission, unlike the precomputed AlphaMissense score.

Clinical Evidence

ClinVar classificationUncertain significance
Review statuscriteria provided, multiple submitters, no conflicts
Associated conditionsWolfram syndrome 1; Type 2 diabetes mellitus; Autosomal dominant nonsyndromic hearing loss 6; WFS1-Related Spectrum Disorders
Population frequency (gnomAD v4)Ultra-rare · AF 0.0031%
cDNA changec.176C>T
ClinVar accessionVCV000903895
Last evaluated2025/03/05 00:00

Observed at very low frequency in gnomAD.

Full Variant Card

A59V — WFS1 Molecular Atlas Card

Variant type: Missense Substitution: Alanine (A) → Valine (V) at position 59 Domain context: N-terminal cytoplasmic (intrinsically disordered)

AlphaMissense

  • Pathogenicity score: 0.0744
  • Class: likely benign

AlphaFold confidence

  • pLDDT at residue 59: 28.05

DynaMut2 ΔΔG: not yet computed for this variant — AlphaMissense + AlphaFold confidence shown above. Stability ΔΔG and the wild-type/mutant structural comparison backfill behind this note.

Clinical evidence

  • Classification: Uncertain significance
  • Review status: criteria provided, multiple submitters, no conflicts
  • Associated conditions: Wolfram syndrome 1; Type 2 diabetes mellitus; Autosomal dominant nonsyndromic hearing loss 6; WFS1-Related Spectrum Disorders
  • cDNA change: c.176C>T
  • ClinVar accession: VCV000903895
  • Last evaluated: 2025/03/05 00:00
  • Submissions: 1

Card generated by wolfram-atlas-batch (missense AlphaMissense mint) on 2026-06-08T02:27:33.340619Z. AlphaMissense (Cheng et al. 2023) · AlphaFold model v6 · UniProt O76024.

Therapeutic Strategy Handoff · prediction

Feed this card to Wolfram Intelligence

Download the A59V PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.

Download A59V PDF card ↓Strategies are AI-generated predictions, not validated therapeutics.